Home › ABRAXANE Phase III Study of Patients with Metastatic Pancreatic...
 

Keywords :   


ABRAXANE Phase III Study of Patients with Metastatic Pancreatic...

2013-10-17 14:14:39| Biotech - Topix.net

Celgene International Sarl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine .

Tags: study iii phase patients

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
03.07Hurricane Beryl Public Advisory Number 19
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 19
More »